Prescient Therapeutics opens first US site for PTX-100 trial
Prescient Therapeutics has crossed a major milestone in its international expansion, with the first US...
Prescient Therapeutics has crossed a major milestone in its international expansion, with the first US...

This investor centre was built by Reach Markets
©2026 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.